ANALGESIC EFFICACY OF BUPIVACAINE VERSUS BUPIVACAINE PLUS MAGNESIUM SULPHATE IN TRANSVERSUS ABDOMINIS PLANE BLOCK FOLLOWING ABDOMINAL GYNAECOLOGICAL SURGERY
Phase 1
- Conditions
- Benign and malignant Gynaecological diseasesAnaesthesia
- Registration Number
- PACTR202208499106275
- Lead Sponsor
- Olatunde Towobola
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 74
Inclusion Criteria
American Society of Anaesthesiologists physical status class I – III female adults scheduled for elective abdominal surgery
Exclusion Criteria
Myomectomy
Patients’ refusal
History of relevant drug allergies
Patients on calcium channel blockers
Opioid dependence
Localised skin infection at site of block
Patient with sepsis
Patient with coagulation disorders
Obese patients with BMI > 35kg/m2
Psychiatric illness that would interfere with the perception and assessment of pain
Intra operative finding of a frozen pelvis
Intra operative finding of extensive tissue adhesions
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the pain scores following TAPB using 0.25% plain bupivacaine with or without MgSO4.<br>
- Secondary Outcome Measures
Name Time Method Compare duration of analgesia following TAPB using 0.25% plain bupivacaine with or without MgSO4.